Akoya Biosciences, Inc. (AKYA)
Jul 8, 2025 - AKYA was delisted (reason: acquired by QTRX)
1.290
0.00 (0.00%)
Inactive · Last trade price on Jul 7, 2025

Akoya Biosciences Stock Forecast

Stock Price Forecast

The 7 analysts with 12-month price forecasts for Akoya Biosciences stock had an average target of $2.51, with a low estimate of $1.08 and a high estimate of $5.00.

Price Target: $2.51 (+94.57%)
Analyst Consensus: Hold

Price Target

TargetLowAverageMedianHigh
Price$1.08$2.51n/a$5.00
Change-16.28%+94.57%n/a+287.60%

Analyst Ratings

The average analyst rating for Akoya Biosciences stock from 7 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.

Recommendation Trends

No data available
RatingOct 2026
Strong Buyn/a
Buyn/a
Holdn/a
Selln/a
Strong Selln/a
Totaln/a

Financial Forecast

Revenue This Year
87.60M
from 81.67M
Increased by 7.26%
Revenue Next Year
97.62M
from 87.60M
Increased by 11.44%
EPS This Year
-0.76
from -1.12
EPS Next Year
-0.60
from -0.76
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
42.44M54.92M74.86M96.63M81.67M87.60M97.62M
Revenue Growth
0.49%29.39%36.31%29.09%-15.48%7.26%11.44%
EPS
-9.18-1.65-1.87-1.43-1.12-0.76-0.60
No. Analysts
-----99

Revenue Forecast

Revenue20252026202720282029
High97.7M110.3M
Avg87.6M97.6M
Low76.0M89.1M

Revenue Growth

Revenue Growth20252026202720282029
High
19.6%
25.9%
Avg
7.3%
11.4%
Low
-7.0%
1.7%

EPS Forecast

EPS20252026202720282029
High-0.46-0.36
Avg-0.76-0.60
Low-0.90-0.67

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--